Clinical trialNCT00628238UnknownPhase 2Interventional

Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)

SponsorChronic Lymphocytic Leukemia Research ConsortiumEnrollment80CLLChronic Lymphocytic LeukemiaFirst-LineFront-lineInitial TherapyUntreated

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Danelle F James, M.D.
CLL Research Consortium and University of California San Diego
Principal Investigator
clinicaltrials.gov ↗
Thomas J Kipps, M.D., Ph.D
Director of the CLL Research Consortium and University of California San Diego
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of California San Diego
La Jolla, California, United States
Danelle F James, M.D.Thomas J Kipps, M.D., Ph.D.
Recruiting
Dana-Farber/harvard Cancer Center at Dana Farber Cancer Institute
Boston, Massachusetts, United States
Jennifer R Brown, M.D.,Ph.D
Recruiting
Long Island Jewish Medical Center
New Hyde Park, New York, United States
Kanti Rai, M.D.
Recruiting
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University
Columbus, Ohio, United States
John Byrd, M.D.Michael Grever, M.D.Thomas Lin, M.D.
Not, yet, recruiting
M. D. Anderson Cancer Center at University of Texas
Houston, Texas, United States
Michael J Keating, M.D., B.S.William G Wierda, M.D., Ph.D.
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Lenalidomide and Rituximab

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 29 Feb 2008
Primary completion: 28 Feb 2011
Completion: 31 Jul 2011
Last update posted: 10 Sept 2010
Registered enrollment: 80
Registry id: NCT00628238

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.